Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences

Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences

US Patent 5993824 · Granted Nov 30, 1999

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant metapneumovirus f proteins and their use2025
Development of dengue virus vaccine components2025
Development of dengue virus vaccine components2025
Method of vaccination with an attenuated RSV vaccine formulation2024
Chimeric vectors2024
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated2024
Attenuation of human respiratory syncytial virus by genome scale codon-pair deop2024
Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f p2024
Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its2024
Pan-ebola virus neutralizing human antibodies and methods of use therefor2024
Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shif2024
Recombinant metapneumovirus F proteins and their use2023